Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06640374

Role of Clinical Pulmonary Infection Score and Sonopulmonary Infection Score in Diagnosis and Predicting Outcome of VAP in RUCU

-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively

The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:

community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively

The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:

community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient 18 yrs or more Mechanically ventilated patients after 48 hrs after admission of ICU

Exclusion criteria

  • Patient less than 18 yrs Patients diagnosed as pneumonia

Treatment and study plan

Primary outcomes

  1. Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients

    Time frame: 4 years

    Diagnosis of VAP in RICU Patients

Secondary outcomes

  1. Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients

    Time frame: 4 years

    Diagnosis of VAP in RICU PATIENTS

Study contacts

Contact information is provided by the study sponsor or research team.

Esraa Khaled Abo hossiba, Resident doctor

CONTACT

[email protected]

01126914592

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2027
First posted
Oct 15, 2024
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.